GS vs KMTS · P/E 20, rev $37.56B vs rev $95.1M
Goldman Sachs Group Inc (GS) versus Kestra Medical Technologies, Ltd. Common Stock (KMTS) — a side-by-side from cached financials, not a winner call.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a medical instruments & supplies company listed on US.
Latest reported GS revenue for 2026-06-30 was $37.56B. Net income was $12.26B. GS currently screens at market cap $324.25B and trailing P/E 20.1.
Latest reported KMTS revenue for 2026-04-30 was $95.1M. Net income was -$131.6M. Revenue was up 59.0% from 2025-04-30 to 2026-04-30. KMTS currently screens at market cap $1.24B.
GS currently screens at market cap $324.25B and trailing P/E 20.1. KMTS currently screens at market cap $1.24B.
Not investment advice. Open the GS and KMTS stock pages for the full models.
Not investment advice.